NCT06906341 2025-10-22
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Corcept Therapeutics
Phase 2 Recruiting
Corcept Therapeutics
Arsenal Biosciences, Inc.
Second Affiliated Hospital of Wenzhou Medical University